Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.03.01
关于使用自有资金购买低风险理财产品的公告
2019.02.28
2018年度业绩快报
2019.02.02
关于第三期员工持股计划完成股票购买的公告
2019.01.29
关于第三期员工持股计划的进展公告
2019.01.26
关于向合格投资者公开发行公司债券获得中国证券监督管理委员会核准批复的公告
2019.01.18
关于控股子公司股权架构调整及对外融资的进展公告
2019.01.05
对控股子公司增资的进展公告
2018.12.29
招商资管-公司员工持股计划单一资产管理合同
2018.12.29
2018年第五次临时股东大会决议公告
2018.12.29
2018年第五次临时股东大会的法律意见书
第一页
上一页
50
51
52
53
54
下一页
最后一页
